Dachau, Germany

Christine Rothe

USPTO Granted Patents = 26 

 

 

Average Co-Inventor Count = 8.3

ph-index = 5

Forward Citations = 139(Granted Patents)


Location History:

  • Dauchau, DE (2015 - 2019)
  • Freising, DE (2018 - 2021)
  • Dachau, DE (2010 - 2024)

Company Filing History:


Years Active: 2010-2025

Loading Chart...
Loading Chart...
Loading Chart...
26 patents (USPTO):Explore Patents

Title: **The Innovative Contributions of Christine Rothe in Biopharmaceuticals**

Introduction

Christine Rothe, a prominent inventor based in Dachau, Germany, has a remarkable portfolio consisting of 26 patents. Her innovative work primarily focuses on the development of proteins that target specific human receptors, emphasizing pharmaceutical applications, particularly in the fields of oncology and immunology.

Latest Patents

Among her latest innovations are the patents involving human lipocalin muteins that bind CD137. These muteins hold promise as anti-cancer agents and immune modulators, with potential applications in treating and preventing various human diseases, including cancer, infectious diseases, and autoimmune disorders. Additionally, her patent on an anti-cancer fusion polypeptide capable of binding both CD137 and glypican-3 (GPC3) outlines its utility in directing CD137 clustering and activation to GPC3-positive tumor cells, representing a significant advancement in targeted cancer therapies. Both patents also describe methods for creating these innovative polypeptides and their nucleic acid counterparts, underscoring their therapeutic and diagnostic potential.

Career Highlights

Christine has made significant contributions to the biopharmaceutical industry through her work at Pieris Pharmaceuticals GmbH and Sanofi. In these roles, she has focused on transformative innovations, leading research and development efforts that have the potential to change treatment paradigms in cancer therapy and immune modulation.

Collaborations

Throughout her career, Christine has collaborated with notable professionals, including Andrea Allersdorfer and Marlon Hinner. These partnerships have facilitated the advancement of her research and the practical application of her inventions in the pharmaceutical sector.

Conclusion

In summary, Christine Rothe's contributions to the field of biopharmaceuticals are profound and impactful. With her extensive patent portfolio and commitment to innovation, she continues to push the boundaries of medical science, offering hope for more effective treatments for various diseases. Her work exemplifies the importance of research and development in the ongoing quest to improve healthcare outcomes through innovative inventions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…